(Photo courtesy of CHOP)
The two institutions had already connected for a year-long pilot application of Blackfynn’s data analytics platform for neuroscience research. That period has now been extended to an indeterminate amount of time.
According to the renewed agreement, the system will also be used by both CHOP and the Children’s Brain Tumor Tissue Consortium (CBTTC) to “bring together complex non-identifiable patient data for collaboration and analysis” for pediatric brain cancer research.
Though founder Amanda Christini declined to comment on the financial detail she did say the partnership now allows for an expanded use of the platform, including multiple vertients of data.
“We are thrilled to expand our relationship with CHOP, whose commitment to enabling translational research through collaboration and data access inspires us every day,” said Christini in a press release. “We share their core belief that transformational discovery will only occur when experts can effectively use the vast amounts of disparate, complex data generated in research. Blackfynn’s Data Platform will fundamentally enable this goal.”-30-
NeuroFlow is teaming up with a genetic testing biz to advance its mental health platform
Check out this interactive report comparing the health of Philly’s neighborhoods
Old City medtech startup Strados Labs set to hire after raising $1.8M
Why this dev planted roots at The Philadelphia Inquirer after starting her career abroad
Get access to 100 services on the new website for Philly’s health department
These Jefferson students are co-inventing tomorrow’s healthcare technology
How a Philly company is building online communities around chronic conditions
Meet these 10 hiring companies at Super Meetup
Sign-up for daily news updates from Technical.ly Philadelphia